Your trusted source for investing success

Tag: pharma

DelMar Pharmaceuticals Receives Approval from China’s Human Genetic Resources Administration to Initiate Phase 2 Clinical Trial in Newly Diagnosed GBM

DelMar Pharmaceuticals Receives Approval from China’s Human Genetic Resources Administration to Initiate Phase 2 Clinical Trial in Newly Diagnosed GBM

DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI), a biopharmaceutical company focused on the development of new cancer therapies, today announced that the Human Genetic Resources Administration of China (HGRAC), has approved the Company’s application to initiate a Phase 2 safety and efficacy study of its lead product candidate VAL-083 in newly diagnosed MGMT-unmethylated glioblastoma

Valens GroWorks Appoints President

Valens GroWorks Appoints President

Valens GroWorks (CSE:VGW)(CSE:VGW.CN) (the “Company” or “Valens“)  is pleased to announce that Mr. Saul Katz has joined the Company as its President.

Mr. Katz brings to Valens 35 years of entrepreneurship, senior management experience and scientific expertise in functional food product development and commercialization. Over his career he established research collaborations with leading

Canadian Marijuana Stocks

Canadian Marijuana Stocks

The Canadian marijuana sector is one of the hottest growing sectors. Here’s a look at Canadian cannabis companies for investors to consider.

The Green Organic Dutchman Holdings Ltd. Hires New President & Strategic Advisor

The Green Organic Dutchman Holdings Ltd. Hires New President & Strategic Advisor

The Green Organic Dutchman Holdings Ltd. (the “Company”) is pleased to announce, following an extensive search, the appointment of Csaba Reider as the Company’s new President and Marc Bertrand as the Company’s new Strategic Advisor.
Csaba Reider

Mr. Reider is a high-energy senior executive with multinational experience in growing companies through demonstrated

Enter Your Log In Credentials
×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network